Proprotein Convertase Subtilisin/kexin Type 2 (PCSK2) Peptide
Quick Overview for Proprotein Convertase Subtilisin/kexin Type 2 (PCSK2) Peptide (ABIN940185)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- LASTFSNGRK RNPEAGVATT DLYGNCTLRH SGTSAAAPEA AGVFALALEA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PCSK2 antibody,
Alternative Names: PCSK2 control peptide, PCSK2 antibody Blocking Peptide, Anti-PCSK2 Blocking Peptide, proprotein convertase subtilisin/kexin type 2 Blocking Peptide, NEC2 Blocking Peptide, PC2 Blocking Peptide, SPC2 Blocking Peptide, PCSK2, PCSK-2, PCSK 2, PCSK-2 Blocking Peptide, PCSK 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PCSK2 (Proprotein Convertase Subtilisin/kexin Type 2 (PCSK2))
-
Background
- This gene encodes a member of the subtilisin-like proprotein convertase family. These enzymes process latent precursor proteins into their biologically active products. The encoded protein plays a critical role in hormone biosynthesis by processing a variety of prohormones including proinsulin, proopiomelanocortin and proluteinizing-hormone-releasing hormone. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
-
Molecular Weight
- 58 kDa
Target
-